Diagnostics (Apr 2024)

Imaging Considerations before and after Liver-Directed Locoregional Treatments for Metastatic Colorectal Cancer

  • David-Dimitris Chlorogiannis,
  • Amgad M. Moussa,
  • Ken Zhao,
  • Erica S. Alexander,
  • Constantinos T. Sofocleous,
  • Vlasios S. Sotirchos

DOI
https://doi.org/10.3390/diagnostics14070772
Journal volume & issue
Vol. 14, no. 7
p. 772

Abstract

Read online

Colorectal cancer is a leading cause of cancer-related death. Liver metastases will develop in over one-third of patients with colorectal cancer and are a major cause of morbidity and mortality. Even though surgical resection has been considered the mainstay of treatment, only approximately 20% of the patients are surgical candidates. Liver-directed locoregional therapies such as thermal ablation, Yttrium-90 transarterial radioembolization, and stereotactic body radiation therapy are pivotal in managing colorectal liver metastatic disease. Comprehensive pre- and post-intervention imaging, encompassing both anatomic and metabolic assessments, is invaluable for precise treatment planning, staging, treatment response assessment, and the prompt identification of local or distant tumor progression. This review outlines the value of imaging for colorectal liver metastatic disease and offers insights into imaging follow-up after locoregional liver-directed therapy.

Keywords